Seizure. Grandmal seizures, unspecified (with or without petit mal
Conditions
Interventions
Treatment - Drugs
Third intervention group: standard monitoring and pre-oxygenation with 100% FiO2 for 3 minutes
Intervention 1: Third intervention group: standard monitoring and pre-oxygenation with 100% FiO2 for 3 minutes
Anesthesia with intravenous Propofol (0.6 mg/kg)
Administration of intravenous Succinyl Colin (0.5 mg/kg) as muscle relaxant and intravenous Atropine (0.1 mg/kg) for prevention of bradycardia. Intervention 2: First intervention group: standard monit
Anesthesia with intravenous Thiopental (1.5 mg/kg)
Administration of intravenous Succinyl Colin (0.5 mg/kg) as muscle relaxant and intravenous Atropine (0.1 mg/kg) for prevention of bradycardia. Intervention 3: Second intervention group: standard moni
Anesthesia with intravenous Etomidate (0.1 mg/kg)
Administration of intravenous Succinyl Colin (0.5 mg/kg) as muscle relaxant and intravenous Atropine for prevention of bradycardia.
Administration of intravenous Succinyl Colin (0.5 mg/kg) as muscle relaxant and intravenous Atropine (0.1 mg/kg) for prevention of bradycardia
First intervention group: standard monitoring and pre-oxygenation with 100% FiO2 for 3 minutes
Administration of intravenous Succinyl Colin (0.5 mg/kg) as muscle relaxant and intravenous Atropine (0.1 mg/kg) for prevention of bradycardia.
Second intervention group: standard monitoring and pre-oxygenation with 100% FiO2 for 3 minutes
Sponsors
Vice Chancellor for Research, Golestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Age between 15 to 50 years; Having psychiatric disorders based on DSM-IV diagnostic criteria and indication for ECT according to psychologist`s opinion. Exclusion Criteria: Having cardiovascular diseases and hypertension; Using medications affecting the duration of seizure; and Contraindication for ECT.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of Seizure. Timepoint: Following ECT, from beginning of seizure to end of it. Method of measurement: by chronometer in second. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of Recovery. Timepoint: Recovery of consciousness after induction of anesthesia. Method of measurement: By chronometer in second.;Changes of hemodynamic parameters including heart rate in beat per minute and mean arterial pressure in millimeter mercury according to systolic and diastolic blood pressure. Timepoint: During the study. Method of measurement: Recording of the non-invasive hemodynamic monitoring device.;Amount of charge for ECT. Timepoint: During setting up the ECT device. Method of measurement: Observation of the ECT Device Settings. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ramin Amini
Golestan University of Medical Sciences
Outcome results
None listed